Company: XAIR
Filing Date: 2025-06-20
Form Type: 10-K
Source: 0001641172-25-015750
Chunk: 2632

Company: Beyond Air, Inc.
Filing Date: 2025-06-20
Form: 10-K
Item: Item 10
Chunk 2632
---
 to the
    Company in 2024 and received an additional 125,000 options to purchase shares of Beyond Air’s common stock. Compensation expense
    was based upon the grant date fair value of the award in accordance with stock-based compensation rules under ASC Topic 718. As of
    March 31, 2025, the aggregate number of options to purchase Beyond Air’s common stock held by each director on the Board of
    Directors was as follows: (i) 273,000 by Dr. Forbes; (ii) 285,000 by Mr. Lucera; (iii) 280,000 by Ms. Lee; and (v) 461,000 by Mr.
    Carey. As of March 31, 2025, Mr. Carey additionally held an aggregate of 65,000 options to purchase Beyond Cancer’s common
    stock and 19,125 options to purchase NeuroNos common stock. 

    (2)
    The
    respective agreements include a change of control provision that would automatically vest any unvested stock options if triggered.

ITEM
12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

The
table below sets forth information with respect to the beneficial ownership of our common stock by each person known by us to beneficially
own more than 5.0% of any class of our voting securities together with:

    ●
    each
    of our directors;

    ●
    each
    of our named executive officers; and

    ●
    all
    of our directors and executive officers as a group.

The
percentages of common stock beneficially owned are reported on the basis of regulations of the SEC governing the determination of beneficial
ownership of securities. Except as indicated in the footnotes to this table, each beneficial owner named in the table below has sole
voting and sole investment power with respect to all shares beneficially owned. Percentage computations are based on 92,469,476
shares of our common stock outstanding as of June 16, 2025.

Under
the terms of the warrants issued by us to each of the 5% holders named below, Robert Carey and Steven Lisi, none of the aforementioned
may exercise a warrant to the extent such exercise would cause them, together with their affiliates and any other persons acting as a
group with them or any of their affiliates, to have acquired a number of shares of common stock which would exceed 9.